Report / Business
Published by NOISE
Pharma stocks rise as investors diversify beyond AI-heavy portfolios
From Morning NOISE.
The Financial Times reports that pharmaceutical stocks have outpaced the broader market as investors diversify away from concentrated AI exposure, with the S&P 500 Pharmaceutical index gaining 18% in the first eight months versus 13% for the S&P 500. White House pricing agreements, tariff relief, strong clinical-trial results and increased biotech dealmaking have supported the sector. The FT also notes that rising US valuations are prompting investors to consider undervalued European drugmakers.
Reporting used
Saved versions
These dates record changes to NOISE’s copy. They are not event dates.